reglab/housing_qa huggingface dataset:
AL Code § 20-2-259 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2 - Controlled Substances.|Article 11 - Prescribing of Certain Schedules of Controlled Substances by Certified Registered Nurse Practitioners and Certified Nurse Midwives.|Section 20-2-259 - Rules.

Section 20-2-259Rules.  The Board of Medical Examiners may adopt rules necessary to carry out the intent, purposes, and provisions of this article. (Act 2013-223, p. 531, §1.)
AL Code § 20-2-260 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2 - Controlled Substances.|Article 12 - Limited Purpose Schedule Ii Permit.|Section 20-2-260 - Permit Authorized.

Section 20-2-260Permit authorized.  (a) The Board of Medical Examiners may at any future date it chooses create a Limited Purpose Schedule II Permit (LPSP), and assess fees associated with the permit, that, along with any other necessary registration, may permit assistants to physicians, certified registered nurse practitioners, or certified nurse midwives to lawfully prescribe, administer, authorize for administration, or dispense only those controlled substances listed in Schedule II substances of Article 2 of Chapter 2 of this title in accordance, as specified and limited by the permit, with rules adopted by the board and any protocols, formularies, and medical regimens established by the board for regulation of a LPSP. Any protocols, formularies, and medical regimens shall not be considered administrative rules under the Alabama Administrative Procedure Act. (b) An assistant to physician, certified registered nurse practitioner, or certified nurse midwife shall not utilize his or her LPSP for the purchasing, obtaining, maintaining, or ordering of any stock supply or inventory of any controlled substance in any form. (c) An assistant to physician, certified registered nurse practitioner, or certified nurse midwife authorized to prescribe, administer, or dispense controlled substances in accordance with this article shall not prescribe, administer, or dispense any controlled substance to his or her own self, spouse, child, or parent. (d) The board may not permit assistants to physicians, certified registered nurse practitioners, or certified nurse midwives to lawfully prescribe, administer, authorize for administration, or dispense all controlled substances listed in Schedule II of Article 2 of Chapter 2 of this title. It is the intent of this article, if and when the board chooses to use this authority at some future date, that the LPSP may be used only at the board's discretion and as limited by the board to specific circumstances and specific drugs. (Act 2013-223, p. 531, §2.)
AL Code § 20-2-281 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2 - Controlled Substances.|Article 13 - Opioid Antagonist Administration.|Section 20-2-281 - Individuals Under Age of 21 Seeking Medical Assistance for Another.

Section 20-2-281Individuals under age of 21 seeking medical assistance for another.  (a) Notwithstanding any other law to the contrary, an individual under 21 years of age may not be prosecuted for the possession or consumption of alcoholic beverages if law enforcement, including campus safety police, became aware of the possession or consumption of alcohol solely because the individual was seeking medical assistance for another individual under this article. (b) Excluding Section 32-5A-191, an individual may not be prosecuted for a misdemeanor controlled substance offense if law enforcement became aware of the offense solely because the individual was seeking medical assistance for another individual under this article. (c) This section shall apply if, when seeking medical assistance on behalf of another, the individual did all of the following: (1) Acted in good faith, upon a reasonable belief that he or she was the first to call for assistance. (2) Used his or her own name when contacting authorities. (3) Remained with the individual needing medical assistance until help arrived. (Act 2015-364, §2.)
AL Code § 20-2-282 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2 - Controlled Substances.|Article 13 - Opioid Antagonist Administration.|Section 20-2-282 - Training of Law Enforcement Officers to Carry and Administer Opioid Antagonists.

Section 20-2-282Training of law enforcement officers to carry and administer opioid antagonists.  On or before January 1, 2016, the Alabama Department of Public Health shall approve a specific training curriculum for completion by law enforcement officers who elect to carry and administer opioid antagonists. (Act 2015-364, §3.)
AL Code § 20-2-283 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2 - Controlled Substances.|Article 13 - Opioid Antagonist Administration.|Section 20-2-283 - Publication of Standing Orders, etc., for Dispensing Opioid Antagonists.

Section 20-2-283Publication of standing orders, etc., for dispensing opioid antagonists.  The State Health Officer or the respective county health officers shall have authority to publish the standing order or orders, including any necessary guidelines or other requirements that shall be followed, for dispensing opioid antagonists under Section 20-2-280 in their jurisdictions. (Act 2016-307, §1.)
AL Code § 20-2-284 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2 - Controlled Substances.|Article 13 - Opioid Antagonist Administration.|Section 20-2-284 - Authority to Dispense Opioid Antagonists.

Section 20-2-284Authority to dispense opioid antagonists.  Any individual dispensing an opioid antagonist pursuant to Section 20-2-280 who is otherwise qualified, including a registered nurse in the employment of the State Health Department or a county health department, and who complies with the standing order or orders and other requirements of the State Health Office or a county health officer shall have authority to dispense an opioid antagonist as provided under Section 20-2-280. (Act 2016-307, §2.)
AL Code § 20-2-300 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2 - Controlled Substances.|Article 14 - Treatment of Opioid; Mat.|Section 20-2-300 - Short Title.

Section 20-2-300Short title. This article shall be known and may be cited as the MAT Act of 2019. (Act 2019-500, §1.)
AL Code § 20-2-302 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2 - Controlled Substances.|Article 14 - Treatment of Opioid; Mat.|Section 20-2-302 - Construction of Article.

Section 20-2-302Construction of article. Because the intent of the Legislature in this article is to educate physicians and to mitigate patient abuse and diversion of buprenorphine, nothing in this article shall modify, amend, repeal, or supersede any provision of Section 6-5-333, the Alabama Medical Liability Act of 1987, commencing with Section 6-5-540, the Alabama Medical Liability Act of 1996, commencing with Section 6-5-548, any amendment to any of the foregoing, or any judicial interpretation of any of the foregoing, nor shall anything in this article modify, amend, repeal, or supersede the law of or pertaining to the standard of care and admissibility of evidence regarding the standard of care. (Act 2019-500, §3.)
AL Code § 20-2A-1 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 1 - General Provisions.|Section 20-2A-1 - Short Title.

Section 20-2A-1Short title. This chapter shall be known and may be cited as the Darren Wesley 'Ato' Hall Compassion Act. (Act 2021-450, §1.)
AL Code § 20-2A-4 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 1 - General Provisions.|Section 20-2A-4 - Relation to Other Laws.

Section 20-2A-4Relation to other laws. This chapter supersedes state criminal and civil laws pertaining to the recommending, acquisition, possession, use, cultivation, manufacturing, processing, research and development, and sale of medical cannabis. The acquisition, possession, use, cultivation, manufacturing, processing, research and development, transportation, testing, or sale of cannabis or medical cannabis in compliance with this chapter and rules of the commission does not constitute a violation of Article 5 of Chapter 12 of Title 13A, or any other law to the contrary. (Act 2021-450, §1.)
AL Code § 20-2A-5 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 1 - General Provisions.|Section 20-2A-5 - Data Security.

Section 20-2A-5Data Security. All data related to the implementation of this chapter, including, but not limited to, application forms, licensing information, physician certifications, registration of qualified patients and designated caregivers, compliance, and the status of cannabis research programs must be maintained in a secure system developed or procured by the commission. Data may not be sold, and patient information shall remain confidential, except as otherwise permitted pursuant to this chapter, and may not be transferred or sold. (Act 2021-450, §1.)
AL Code § 20-2A-8 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 1 - General Provisions.|Section 20-2A-8 - Diversion of Medical Cannabis or Medical Cannabis Products; Prohibited Conduct.

Section 20-2A-8Diversion of medical cannabis or medical cannabis products; prohibited conduct. (a)(1) An individual may not distribute, possess, manufacture, or use medical cannabis or a medical cannabis product that has been diverted from a registered qualified patient, a registered caregiver, or a licensed cultivator, processor, secure transporter, dispensary, or a state testing laboratory. (2) An individual who violates this section is guilty of a Class B felony. (3) The penalty under this section is in addition to any penalties that a person may be subject to for manufacture, possession, or distribution of marijuana under Title 13A. (b) This chapter does not permit any individual to engage in, and does not prevent the imposition of any civil, criminal, or other penalty for engaging in any of the following conduct: (1) Undertaking any task under the influence of cannabis, when doing so would constitute negligence, professional malpractice, or professional misconduct, or violation of law. (2) Possessing or using medical cannabis on any property of a K-12 school or day care or child care facility, in any correctional facility, or in a vehicle unless the medical cannabis is in its original package and is sealed and reasonably inaccessible while the vehicle is moving. (Act 2021-450, §1.)
AL Code § 20-2A-9 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 1 - General Provisions.|Section 20-2A-9 - Annual Written Reporst.

Section 20-2A-9Annual written reporst. The commission shall provide annual written reports to the Legislature, with the first due no later than January 1, 2022, tracking implementation of this chapter. The report shall be made publicly available and posted on the commission's website. The report shall include all of the following:  (1) The number of patients applying for and receiving medical cannabis cards.  (2) The qualifying medical conditions identified to obtain the medical cannabis cards.  (3) Comments from physicians and other health care providers and from pharmacists. (4) Revenues and expenses of card issuance and licensing of medical cannabis facilities.  (5) Relevant developments in other states' cannabis laws.  (6) Relevant scientific research.  (7) Applicable tax revenue.  (8) The commission's annual operating expenses and revenues. (9) The number of total applicants for each type of license under Article 4 and the number of veterans, minorities, and women who applied and the number of these applicants who were denied a license. (10) Any other information available to the commission that would inform public officials of how this chapter affects the public. (11) Any suggested legislative changes to this chapter or other state laws, including all of the following: a. Any suggestions to ensure that veterans, women, and minorities are not unfairly discriminated against in obtaining licenses under Article 4. b. Changes to reflect changes in federal law or regulation. c. Changes based on additional medical or scientific research. (Act 2021-450, §1.)
AL Code § 20-2A-10 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 1 - General Provisions.|Section 20-2A-10 - Medical Cannabis Commission Fund.

Section 20-2A-10Medical Cannabis Commission Fund. (a) There is created a special account in the State Treasury to be known as the Medical Cannabis Commission Fund. Expenditures from the Medical Cannabis Commission Fund may be made only by the commission to implement, administer, and enforce this chapter. Specifically, the Medical Cannabis Commission Fund includes all of the following: (1) Tax proceeds collected pursuant to subsections (a) and (b) of Section 20-2A-80, less an amount sufficient to cover the cost of administration of the tax levies imposed under subsections (a) and (b) of Section 20-2A-80, which shall be retained by the Department of Revenue. (2) License fees, civil penalties, and other fees or charges collected pursuant to Article 4. (3) Any monies appropriated by the Legislature for the initial operation of the commission. (b) Amounts in the Medical Cannabis Commission Fund shall be budgeted and allotted in accordance with Sections 41-4-80 through 41-4-96 and Sections 41-19-1 through 41-19-12, but shall not be limited by the fiscal year appropriation cap. (c) Beginning October 1, 2025, any funds in the Medical Cannabis Commission Fund in excess of actual expenses from the previous fiscal year shall be distributed, less 10 percent, as follows: (1) 60 percent shall be transferred to the General Fund. (2) 30 percent shall be transferred to the Medical Cannabis Research Fund established pursuant to subsection (f) of Section 20-2A-120. (Act 2021-450, §1.)
AL Code § 20-2A-11 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 1 - General Provisions.|Section 20-2A-11 - Possession of Lawfully Obtained Medical Cannabis Card.

Section 20-2A-11Possession of lawfully obtained medical cannabis card. The possession of a medical cannabis card lawfully obtained pursuant to this chapter does not infringe on the cardholder's state or federal constitutional rights. (Act 2021-450, §1.)
AL Code § 20-2A-12 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 1 - General Provisions.|Section 20-2A-12 - Severability.

Section 20-2A-12Severability. The provisions of this chapter are severable. If any part of this chapter is declared invalid or unconstitutional, the declaration shall not affect the part that remains. (Act 2021-450, §1.)
AL Code § 20-2A-13 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 1 - General Provisions.|Section 20-2A-13 - Ineligibility to Receive Compensation Due to Impairment of Employee by Medical Cannabis.

Section 20-2A-13Ineligibility to receive compensation due to impairment of employee by medical cannabis. An employee who is injured or killed under circumstances that might otherwise make the employee or the employee's dependents eligible to receive worker's compensation benefits under Chapter 5 of Title 25 is, along with the employee's dependents, ineligible to receive compensation as defined in Section 25-5-1, if the injury or death occurred due to the employee's impairment by medical cannabis, which shall be conclusively presumed in the event of a positive drug test conducted and evaluated pursuant to standards adopted for drug testing by the U.S. Department of Transportation in 49 C.F.R. Part 40, as provided under Section 25-5-51, or if the employee refuses to submit to or cooperate with a blood or urine test, as provided by that section. (Act 2021-450, §3.)
AL Code § 20-2A-21 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 2 - Alabama Medical Cannabis Commission.|Section 20-2A-21 - Commission Members Prohibited From Certain Economic Interests.

Section 20-2A-21Commission members prohibited from certain economic interests. (a) A member of the commission and any individual employed by the commission may not be an owner, shareholder, director, or board member of, or otherwise have any economic interest in, a licensee. In addition, a member or employee of the commission may not have any family member who is employed by a licensee. A member or employee of the commission or his or her family member may not have an interest of any kind in any building, fixture, or premises occupied by any person licensed under this chapter; and may not own any stock or have any interest of any kind, direct or indirect, pecuniary or otherwise, by a loan, mortgage, gift, or guarantee of payment of a loan, in any licensee.  (b) A member or employee of the commission may not accept any gift, favor, merchandise, donation, contribution, or any article or thing of value, from any person licensed under this chapter.  (c) Any individual violating this section shall be terminated from employment or position, and as a consequence, the individual shall forfeit any pay or compensation which might be due.  (d) For purposes of this section, family member includes a spouse, child, parent, or sibling, by blood or marriage. (e) A former member of the commission, for a period of two years after leaving service as a member of the commission, may not be an owner, shareholder, director, board member, or otherwise have an economic interest in an applicant or license issued under Article 4.  (f) In addition to any violation of Chapter 25 of Title 36, a violation of this section is a Class C misdemeanor. (Act 2021-450, §1.)
AL Code § 20-2A-22 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 2 - Alabama Medical Cannabis Commission.|Section 20-2A-22 - This Section Was Assigned by the Code Commissioner in the 2021 Regular Session, Effective May 17, 2021. This Is Not in the Current Code Supplement.

Section 20-2A-22Implementation of chapter; administration and enforcement. (a) The Alabama Medical Cannabis Commission shall implement this chapter by making medical cannabis derived from cannabis grown in Alabama available to registered qualified patients and by licensing facilities that process, transport, test, or dispense medical cannabis. (b) The commission shall administer and enforce this chapter and all rules adopted pursuant to this chapter. (Act 2021-450, §1.)
AL Code § 20-2A-30 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 3 - Physician Certifications, Medical Cannabis Patient Registry, and Medical Cannabis Cards.|Section 20-2A-30 - Registered Qualified Patient; Registered Caregiver.

Section 20-2A-30Registered qualified patient; registered caregiver. (a)(1) A resident of this state who is 19 years of age or older is a registered qualified patient if he or she meets all of the following conditions: a. Has been certified by a registered certifying physician as having a qualifying medical condition. b. Is registered with the commission. c. Has been issued a valid medical cannabis card by the commission.  (2) A registered qualified patient described in subdivision (1) may purchase, possess, or use medical cannabis, subject to subsection (d). (b)(1) A resident of this state who is under the age of 19 is a registered qualified patient if he or she meets all of the following conditions: a. Has been certified by a registered certifying physician as having a qualifying medical condition. b. Is registered with the commission. c. Has a qualified designated caregiver who is the patient's parent or legal guardian. (2) A registered qualified patient described in subdivision (1) may use medical cannabis but may not purchase or possess medical cannabis. (c)(1) A resident of this state is a registered caregiver if he or she meets all of the following conditions: a. Is registered with the commission. b. Has been issued a valid medical cannabis card by the commission. c. Is at least 21 years of age, unless he or she is the parent or legal guardian of, and caregiver for, a registered qualified patient. d. Is the parent, legal guardian, grandparent, spouse, or an individual with power of attorney for health care of a registered qualified patient. (2) A registered caregiver described in subdivision (1) may purchase and possess medical cannabis, subject to subsection (d), but may not use medical cannabis unless he or she is also a registered qualified patient. (3) The commission, by rule, may limit the number of registered qualified patients a registered caregiver may have under his or her care. (4) A registered caregiver may receive compensation for services provided to a registered qualified patient pursuant to this chapter. (d) Notwithstanding subdivision (2) of subsections (a) and (c), a registered qualified patient or registered caregiver may not purchase more than 60 daily dosages of medical cannabis and may not renew the supply more than 10 days before the 60-day period expires. At no time may a registered qualified patient or registered caregiver possess more than 70 daily dosages of medical cannabis. (Act 2021-450, §1.)
AL Code § 20-2A-31 (2021)
2021 Code of Alabama|Title 20 - Food, Drugs and Cosmetics.|Chapter 2A - Darren Wesley "Ato" Hall Compassion Act.|Article 3 - Physician Certifications, Medical Cannabis Patient Registry, and Medical Cannabis Cards.|Section 20-2A-31 - Registered Certifying Physician - Requirements.

Section 20-2A-31Registered certifying physician - Requirements. (a) In order for a physician to qualify as a registered certifying physician, he or she must meet the following requirements: (1) Hold an active license to practice medicine under Chapter 24 of Title 34. (2) Complete a four-hour course related to medical cannabis and complete a subsequent examination, both of which shall be offered by a multi-specialty statewide professional organization of physicians in this state that is recognized to accredit intrastate organizations to provide AMA PRA category 1 credits. The course must be administered at least annually and may be offered in a distance learning format, including an electronic online format upon request. The price of the course may not exceed five hundred dollars ($500). Every two years thereafter, in order to requalify, a certifying physician must complete a two-hour refresher course offered by an entity described in this subdivision. (3) Pay an initial registration fee established by the board, not to exceed three hundred dollars ($300). (4) Meet any additional qualifications established by rule by the board. (b) Upon meeting the requirements of subsection (a), the board shall issue a registration certificate and registration number to each registered certifying physician. The board shall maintain on its website an updated list of registered certifying physicians. (c) The board, by rule, may establish requirements for registered certifying physicians to remain qualified, grounds for revoking registration, and a process for renewing registration of qualified certifying physicians, including payment of an annual registration renewal fee, not to exceed two hundred dollars ($200). (Act 2021-450, §1.)